近年来，重症医学作为应对危重症患者的重要学科，受到越来越多的关注，其发展水平直接关系到医疗体系的整体能力和危重症患者的救治成效。在当前脓毒症、急性呼吸窘迫综合征、多脏器衰竭等重症疾病发病率、致残率及病死率均高，且精准医学需求不断增长的背景下，建设高水平科研平台成为推动重症医学发展的必然选择。本文围绕科研平台在重症医学中的关键作用展开论述，分析其在基础研究、成果转化、多学科协作以及创新技术开发中的重要贡献，同时以多脏器衰竭预警与干预教育部重点实验室为例，提出以学习驱动文化、人才驱动成果、资金驱动项目和范式驱动合作等高水平科研平台建设举措。展望未来，随着人工智能和大数据技术的深入应用，高水平科研平台将推动重症医学向智能化、精准化方向发展，为提升危重症救治能力和实现“健康中国”战略目标提供有力支撑。

In recent years, critical care medicine, a core discipline dedicated to the management of critically ill patients, is increasingly recognized for its vital role in healthcare. Its advancement is pivotal to the overall capacity of the medical system and the outcomes of critically ill patients. In the context of the high incidence, disability rates, and mortality rates of severe conditions like sepsis, acute respiratory distress syndrome, and multiple organ failure, coupled with a growing demand for precision medicine, establishing high-level research platforms has become an imperative for propelling the field forward. This article discusses the critical role of such platforms in critical care medicine, elaborating on their significant contributions to basic research, translational science, multidisciplinary collaboration, and innovative technology development. Taking the Key Laboratory of Multiple Organ Failure of the Ministry of Education as an example, we propose key strategies for building high-level platforms, emphasizing the cultivation of a learning culture, talent development, sustainable funding, and the establishment of novel collaborative paradigms. Looking ahead, with the deepening integration of artificial intelligence and big data technologies, high-level research platforms are poised to drive critical care medicine towards greater intelligence and precision, providing robust support for enhancing treatment capabilities and achieving the strategic goals of the "Healthy China" initiative.